Patents Represented by Attorney, Agent or Law Firm Beth E. Arnold, Esq.
  • Methods for diagnosing sepsis
    Patent number: 6251598
    Abstract: Methods and kits for detecting polymorphism that are predictive of a subject's susceptibility to developing sepsis are described.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: June 26, 2001
    Assignee: Interleukin Genetics, Inc.
    Inventors: Francesco Saverio di Giovine, Gordon W. Duff
  • Compounds useful for the synthesis of dolastatin analogs
    Patent number: 6248865
    Abstract: Compounds of the formula where R1, R2, R3 and R4 have the meaning stated in the description, and a process for preparing them are described. The compounds are suitable as starting material for synthesizing substances which are active against tumors.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: June 19, 2001
    Assignee: BASF Aktiengesellschaft
    Inventors: Wilhelm Amberg, Harald Bernard, Ernst Buschmann, Andreas Haupt, Lothar Janitschke, Bernd Janssen, Ulrich Karl, Andreas Kling, Stefan Müller, Bernd de Potzolli, Kurt Ritter, Marco Thyes, Thomas Zierke
  • Prediction of coronary artery disease
    Patent number: 6210877
    Abstract: Methods and assays are disclosed for predicting a patient's risk for an inflammatory disorder such as coronary artery disease or related vascular disorders. The methods comprise obtaining a biological sample from a patient and determining the presence or absence of a particular allele which is linked with coronary artery disease. Detection of the allele is indicative of susceptibility to develop coronary artery disease. Kits for the detection of coronary artery disease are additionally provided, as are means for identifying additional alleles associated with coronary artery disease.
    Type: Grant
    Filed: March 10, 1997
    Date of Patent: April 3, 2001
    Assignee: Interleukin Genetics, Inc.
    Inventors: Sheila E. Francis, David C. Crossman, Gordon W. Duff
  • Glaucoma therapeutics and diagnostics based on a novel human transcription factor
    Patent number: 6207450
    Abstract: Methods and compositions for treating glaucoma and methods and compositions for prognosing or diagnosing glaucoma in a subject are disclosed.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: March 27, 2001
    Assignee: University of Iowa Research Foundation
    Inventors: Val C. Sheffield, Wallace L. M. Alward, Edwin M. Stone, Darryl Nishimura, Shiva Patil
  • Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
    Patent number: 5587398
    Abstract: Novel meta substituted arylakylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin mediated nerve transmission (e.g. depression and obesity).
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 24, 1996
    Assignee: David R. Elmaleh
    Inventors: David R. Elmaleh, Alan J. Fischman